Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
| 88 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//CHITOSAN | 80849 |
| 1228 | 2 | LIPOSOMES//NIOSOMES//ETHOSOMES | 9338 |
| 7626 | 1 | OPSONIN//DYSOPSONIN//LIPOSOME IMMUNOASSAY | 1370 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | OPSONIN | authKW | 139132 | 2% | 21% | 29 |
| 2 | DYSOPSONIN | authKW | 118301 | 0% | 86% | 6 |
| 3 | LIPOSOME IMMUNOASSAY | authKW | 112712 | 1% | 70% | 7 |
| 4 | CETYLMANNOSIDE | authKW | 92013 | 0% | 100% | 4 |
| 5 | COMPLEMENT ACTIVATING FACTOR CAF | authKW | 92013 | 0% | 100% | 4 |
| 6 | LIPOSOMES | authKW | 86906 | 15% | 2% | 203 |
| 7 | LIPOSOME IMMUNE LYSIS ASSAY | authKW | 73609 | 0% | 80% | 4 |
| 8 | PHARMACOKINET PHARMACEUT | address | 73609 | 0% | 80% | 4 |
| 9 | LIPOSOME CLEARANCE | authKW | 71882 | 0% | 63% | 5 |
| 10 | IMMUNOLIPOSOMES | authKW | 64359 | 2% | 10% | 28 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Biophysics | 4232 | 21% | 0% | 282 |
| 2 | Biochemistry & Molecular Biology | 2789 | 39% | 0% | 532 |
| 3 | Pharmacology & Pharmacy | 1590 | 22% | 0% | 296 |
| 4 | Biochemical Research Methods | 720 | 8% | 0% | 116 |
| 5 | Chemistry, Analytical | 314 | 8% | 0% | 109 |
| 6 | Chemistry, Medicinal | 289 | 5% | 0% | 69 |
| 7 | CYTOLOGY & HISTOLOGY | 180 | 1% | 0% | 8 |
| 8 | Cell Biology | 148 | 7% | 0% | 101 |
| 9 | Immunology | 87 | 6% | 0% | 78 |
| 10 | Chemistry, Multidisciplinary | 84 | 8% | 0% | 113 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARMACOKINET PHARMACEUT | 73609 | 0% | 80% | 4 |
| 2 | PHARMACEUT SCI FUNAGAWARA MACHI SHINJUKU KU | 46007 | 0% | 100% | 2 |
| 3 | AURIS BUSINESS | 23003 | 0% | 100% | 1 |
| 4 | BIOMEMBRANE PHYSICOCHEM | 23003 | 0% | 100% | 1 |
| 5 | CHEM ELECT SYST | 23003 | 0% | 100% | 1 |
| 6 | CONTROLE QUAL 7 RUE FER MOULIN | 23003 | 0% | 100% | 1 |
| 7 | CORNELL ANALYT CHEM S | 23003 | 0% | 100% | 1 |
| 8 | DISPOSIT DYNAM MONASH PHARMACEUT SCI | 23003 | 0% | 100% | 1 |
| 9 | DRUGS OSAKA BRANCH 1143 HOENZAKA CHUO KU | 23003 | 0% | 100% | 1 |
| 10 | DURG DELIVERY | 23003 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOCHIMICA ET BIOPHYSICA ACTA | 19467 | 11% | 1% | 156 |
| 2 | CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 5561 | 1% | 3% | 9 |
| 3 | CANCER DRUG DELIVERY | 4948 | 0% | 4% | 5 |
| 4 | JOURNAL OF LIPOSOME RESEARCH | 4649 | 1% | 2% | 11 |
| 5 | JOURNAL OF IMMUNOLOGICAL METHODS | 2686 | 2% | 0% | 34 |
| 6 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 2236 | 1% | 1% | 15 |
| 7 | ADVANCED DRUG DELIVERY REVIEWS | 2137 | 1% | 1% | 16 |
| 8 | BIOLOGICHESKIE MEMBRANY | 1899 | 1% | 1% | 15 |
| 9 | SELECTIVE CANCER THERAPEUTICS | 1505 | 0% | 3% | 2 |
| 10 | METHODS OF BIOCHEMICAL ANALYSIS | 1349 | 0% | 3% | 2 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | OPSONIN | 139132 | 2% | 21% | 29 | Search OPSONIN | Search OPSONIN |
| 2 | DYSOPSONIN | 118301 | 0% | 86% | 6 | Search DYSOPSONIN | Search DYSOPSONIN |
| 3 | LIPOSOME IMMUNOASSAY | 112712 | 1% | 70% | 7 | Search LIPOSOME+IMMUNOASSAY | Search LIPOSOME+IMMUNOASSAY |
| 4 | CETYLMANNOSIDE | 92013 | 0% | 100% | 4 | Search CETYLMANNOSIDE | Search CETYLMANNOSIDE |
| 5 | COMPLEMENT ACTIVATING FACTOR CAF | 92013 | 0% | 100% | 4 | Search COMPLEMENT+ACTIVATING+FACTOR+CAF | Search COMPLEMENT+ACTIVATING+FACTOR+CAF |
| 6 | LIPOSOMES | 86906 | 15% | 2% | 203 | Search LIPOSOMES | Search LIPOSOMES |
| 7 | LIPOSOME IMMUNE LYSIS ASSAY | 73609 | 0% | 80% | 4 | Search LIPOSOME+IMMUNE+LYSIS+ASSAY | Search LIPOSOME+IMMUNE+LYSIS+ASSAY |
| 8 | LIPOSOME CLEARANCE | 71882 | 0% | 63% | 5 | Search LIPOSOME+CLEARANCE | Search LIPOSOME+CLEARANCE |
| 9 | IMMUNOLIPOSOMES | 64359 | 2% | 10% | 28 | Search IMMUNOLIPOSOMES | Search IMMUNOLIPOSOMES |
| 10 | SERUM OPSONINS | 63894 | 0% | 56% | 5 | Search SERUM+OPSONINS | Search SERUM+OPSONINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |